DE69930166D1 - Verfahren und zusammensetzungen für impfung mit dem pseudomonas aeruginosa v-antigen - Google Patents

Verfahren und zusammensetzungen für impfung mit dem pseudomonas aeruginosa v-antigen

Info

Publication number
DE69930166D1
DE69930166D1 DE69930166T DE69930166T DE69930166D1 DE 69930166 D1 DE69930166 D1 DE 69930166D1 DE 69930166 T DE69930166 T DE 69930166T DE 69930166 T DE69930166 T DE 69930166T DE 69930166 D1 DE69930166 D1 DE 69930166D1
Authority
DE
Germany
Prior art keywords
pseudomonas aeruginosa
antigen
vaccination
compositions
moderating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69930166T
Other languages
English (en)
Other versions
DE69930166T2 (de
Inventor
W Frank
L Yahr
Teiji Sawa
Jeanine Wiener-Kronish
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Medical College of Wisconsin Research Foundation Inc
Original Assignee
University of California
Medical College of Wisconsin Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, Medical College of Wisconsin Research Foundation Inc filed Critical University of California
Application granted granted Critical
Publication of DE69930166D1 publication Critical patent/DE69930166D1/de
Publication of DE69930166T2 publication Critical patent/DE69930166T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/21—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
DE69930166T 1998-11-25 1999-11-23 Verfahren und zusammensetzungen für impfung mit dem pseudomonas aeruginosa v-antigen Expired - Lifetime DE69930166T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10995298P 1998-11-25 1998-11-25
US109952P 1998-11-25
US12679499P 1999-03-30 1999-03-30
US126794P 1999-03-30
PCT/US1999/027796 WO2000033872A2 (en) 1998-11-25 1999-11-23 Method of and compositions for immunization with the pseudomonas v antigen

Publications (2)

Publication Number Publication Date
DE69930166D1 true DE69930166D1 (de) 2006-04-27
DE69930166T2 DE69930166T2 (de) 2006-12-14

Family

ID=26807543

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69930166T Expired - Lifetime DE69930166T2 (de) 1998-11-25 1999-11-23 Verfahren und zusammensetzungen für impfung mit dem pseudomonas aeruginosa v-antigen

Country Status (10)

Country Link
US (2) US6309651B1 (de)
EP (2) EP1666058B1 (de)
JP (2) JP4707234B2 (de)
AT (2) ATE539349T1 (de)
AU (1) AU3580800A (de)
CA (1) CA2318536C (de)
DE (1) DE69930166T2 (de)
DK (1) DK1049488T3 (de)
ES (2) ES2255329T3 (de)
WO (1) WO2000033872A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1353688T3 (da) 2001-01-26 2007-04-10 Mcw Res Found Inc Fremgangsmåde og sammensætninger til immunisering med Psedomonas V-antigenet
AU2007231760B2 (en) * 2001-01-26 2009-10-29 Mcw Research Foundation, Inc. Method and compositions for immunization with the pseudomonas V antigen
EP1425300A2 (de) * 2001-09-13 2004-06-09 Medizinische Hochschule Hannover Phaenotyp bestimmende virulenzgene von pseudomonas aeruginosa zur kolonisation und persistenz in mensch, tier und pflanze, verwendungen der gene und zugehoerige proteine
AU2003226441A1 (en) * 2002-01-11 2003-07-24 Cornell Research Foundation, Inc. Methods of identifying putative effector proteins
EP1528935B1 (de) 2002-08-13 2012-03-21 Haptogen Ltd Verfahren zur behandlung einer bakteriellen infektionskrankheit mittels antikörpern gegen laktone oder gegen von laktonen abgeleiteten signalmolekülen
AU2005207003C1 (en) * 2004-01-20 2013-06-13 Humanigen, Inc. Antibody specificity transfer using minimal essential binding determinants
GB0407008D0 (en) 2004-03-27 2004-04-28 Haptogen Ltd Methods for inducing rapid cell death (autolysis) in infectious bacteria
GB0410958D0 (en) 2004-05-15 2004-06-16 Haptogen Ltd Methods for reducing biofilm formation in infectious bacteria
EP1946768A4 (de) 2005-10-28 2009-11-11 Meiji Seika Kaisha Aussenmantel-protein pa5158 von pseudomonas aeruginosa
KR20080113239A (ko) 2006-03-30 2008-12-29 메이지 세이카 가부시키가이샤 녹농균의 외막 단백질 ｐａ0427
SG182975A1 (en) * 2007-06-29 2012-08-30 Meiji Seika Kaisha Pseudomonas aeruginosa outer membrane protein pa4710
WO2009073631A2 (en) 2007-11-30 2009-06-11 Kalobios Pharmaceuticals, Inc. Antibodies to the pcrv antigen of pseudomonas aeruginosa
SG186682A1 (en) 2007-12-25 2013-01-30 Meiji Seika Kaisha Type iii secretion system component protein pa1698 of pseudomonas aeruginosa
AU2009203426C1 (en) * 2008-01-10 2012-05-31 Shionogi & Co., Ltd. Antibody directed against PcrV
CA2751433A1 (en) 2009-02-04 2010-08-12 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
MX2011009100A (es) 2009-03-11 2011-09-27 Shionogi & Co Anticuerpo humanizado pcrv que tiene actividad anti-pseudomonal.
CA2784033A1 (en) * 2009-12-22 2011-07-21 Kalobios Pharmaceuticals, Inc. A method of treating a staphylococcus infection in a patient having a low-level pathogenic pseudomonas aeruginosa infection
WO2013006449A2 (en) * 2011-07-01 2013-01-10 The Trustees Of The University Of Pennsylvania Anti-properdin antibodies and uses thereof
JP6182152B2 (ja) 2011-11-07 2017-08-16 メディミューン，エルエルシー 抗シュードモナス属（Ｐｓｅｕｄｏｍｏｎａｓ）ＰｓｌおよびＰｃｒＶ結合分子を用いた併用治療
CA2887050A1 (en) 2012-10-04 2014-04-10 Novelmed Therapeutics, Inc. Alternative pathway specific antibodies for treating hemolytic diseases
CN110028559B (zh) * 2019-04-15 2022-06-10 中国人民解放军陆军军医大学 一种铜绿假单胞菌疫苗重组蛋白及其编码基因和它们的应用
WO2021031270A1 (zh) * 2019-08-22 2021-02-25 四川大学 细菌膜囊泡及其分离制备系统和方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3178014B2 (ja) * 1991-07-05 2001-06-18 東ソー株式会社 Ｒｎａの測定方法
US5599665A (en) 1993-12-21 1997-02-04 Mcw Research Foundation Pseudomonas aeruginosa nucleic acids encoding exoenzyme S activity and use thereof in detecting pseudomonas aeruginosa infection

Also Published As

Publication number Publication date
JP2002531522A (ja) 2002-09-24
JP2011068672A (ja) 2011-04-07
EP1666058A2 (de) 2006-06-07
EP1666058B1 (de) 2011-12-28
AU3580800A (en) 2000-06-26
DE69930166T2 (de) 2006-12-14
DK1049488T3 (da) 2006-06-26
ATE318613T1 (de) 2006-03-15
US6827935B2 (en) 2004-12-07
WO2000033872A2 (en) 2000-06-15
ES2255329T3 (es) 2006-06-16
EP1049488A1 (de) 2000-11-08
JP4707234B2 (ja) 2011-06-22
US20040208888A1 (en) 2004-10-21
WO2000033872A3 (en) 2000-10-19
WO2000033872A9 (en) 2000-12-14
EP1666058A3 (de) 2008-03-12
ES2379801T3 (es) 2012-05-03
EP1049488B1 (de) 2006-03-01
CA2318536A1 (en) 2000-06-15
CA2318536C (en) 2009-11-17
US6309651B1 (en) 2001-10-30
ATE539349T1 (de) 2012-01-15

Similar Documents

Publication Publication Date Title
DE69930166D1 (de) Verfahren und zusammensetzungen für impfung mit dem pseudomonas aeruginosa v-antigen
DE60216564D1 (de) Verfahren und zusammensetzungen für immunisierung mit dem pseudomonas antigen
PT1106723E (pt) Tampao de algodao hidrofilo destinado aos cuidados da pele e que compreende duas faces exteriores diferentes
DE3789874D1 (de) Thermometrisches verfahren für lebende organismen und gerät dazu.
ID27671A (id) Piranti pembersih endoskop
DE3788787D1 (de) EINRICHTUNG ZUR EINSTELLUNG EINES HöRGERÄTES DURCH DEN PATIENTEN , VERFAHREN UND TESTEINRICHTUNG FÜR DIESES HöRGERÄT.
DE69939956D1 (de) Verwendung von Myoblasten zur Herstellung eines Medikaments zur Behandlung der stressbedingten Harninkontinenz
TR200001288T2 (tr) Östrojen yoksunluğu sendromunun tedavisinde faydalı 2-arilbenzo (b) tiyofenler.
ATE325621T1 (de) Il-12 als adjuvanz für bordetella pertussis impfstoffe
DE69723243D1 (de) Sterilisationsschutzmittel und verfahren zur sterilisation
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
DE69109300D1 (de) Markierungen für dentalradiographischen film und pakete zur vereinfachten filmmontierung.
ES2065932T3 (es) Anticuerpo monoclonal contra pseudomonas aeruginosa, su preparacion y empleo.
ATE210460T1 (de) Zusammensetzungen, welche adp-ribosyltransferase- aktivität aufweisen und methoden für ihre herstellung und die verwendung derselben
NO903338L (no) Fremgangsmaate for mikrobiologisk fremstilling av l-carnitin.
DE59605867D1 (de) Vorrichtung zur Halterung und Führung einer Achse oder Welle
ATE206138T1 (de) Helicobacter pylori antigen
DE58902675D1 (de) Verfahren zur steigerung des anteils an siliciumtetrachlorid.
ATE377944T1 (de) Methode für die behandlung einer hepatitisvirusinfektion
ES2179867T3 (es) Entrecruzamientos de piridinolina como marcadores de actividad de enfermedad periodontal o peri-implante.
ATE165166T1 (de) Paracetamolphosphat für immunoassays
DE59005556D1 (de) Verfahren und einrichtung zur überprüfung des abschalt-drehmomentes eines stellantriebes.
IT233341Y1 (it) Dispositivo di fissaggio per protesi dentale con meccanismo atto alla eliminazione dei fenomeni di usura.
IT1278050B1 (it) Derivati poliossidrilati delle rifamicine ad attivita' antimicrobica e metodi per la loro preparazione.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition